The drug is used to treat a form of blood cancer ... and plaque psoriasis. The blood thinner Eliquis was Bristol Myers Squibb’s highest revenue-generating medication last year.

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

Pfizer (NYSE:PFE) is overhauling its cardiometabolic pipeline and weighing acquisitions after an oral weight-loss candidate ...

Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...

In addition, alliance revenues and direct sales from Eliquis are likely to have provided ... like the Velsipity pill for ulcerative colitis, the pentavalent meningococcal vaccine Penbraya, and ...

Pfizer (PFE) stock slips after the company's lower than expected Q1 2025 revenue and the firm seeks acquisitions to boost its ...